CERS Kevin Dennis Green sells $96K worth of shares
Mar 06, 2025, 5:31 AM
0.00%
What does CERS do
Cerus, headquartered in Concord, California, focuses on developing the INTERCEPT Blood System to enhance blood safety by reducing pathogens in transfusion blood components. The company employs 288 people and specializes in various blood products.
Kevin Dennis Green sold 60,656 shares of CERS on 3 March at $1.58 per share, worth a total of $96K. They now own 493,862 CERS shares, or a 11% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
